A2A-O-04

N/A

Report date: 2022/02/18 10:20:03
NME

Base Information

Drug NameA2A-O-04
Drug Alias NameA2A_O-04A2A-O-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming acidic coiled-coil-containing protein 3 inhibitors
TargetsTransforming acidic coiled-coil-containing protein 3
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA2A Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesA2A Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A